Get startedLog in
    Picture of Phaxiam Therapeutics SA logo

    PHXM — Phaxiam Therapeutics SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapValue Trap
    All News

    Brief: ERYTECH Announces Publication Of Positive Results From Eryaspase Phase 2 Trial In Hypersensitive ALL In The British Journal Of Haematology

    Picture of Phaxiam Therapeutics SA logoPhaxiam Therapeutics SA
    06/04/2022 22:39
    April 6 (Reuters) - Erytech Pharma SA  ERYP.PA :
    * ERYTECH ANNOUNCES PUBLICATION OF POSITIVE RESULTS FROM
ERYASPASE
PHASE 2 TRIAL IN HYPERSENSITIVE ALL  IN THE BRITISH JOURNAL OF
HAEMATOLOGY

Source text for Eikon:  ID:nGNX666tjD 
Further company coverage:  ERYP.PA 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Phaxiam Therapeutics SA

    See all news